CD34 and acute myeloid leukemia: In acute myeloid leukemia (AML), Bonnet and Dick first detected cells having similar characteristics to normal hematopoietic stem cells with the same markers (CD34+ and CD38−) that were much more prone to developing leukemia, which were referred as leukemic stem cells (LSCs) or CSCs [6].